A study which supports this idea showed that in patients with idiopathic pulmonary fibrosis (IPF), ANXA1 was associated with increased CD4+ T‐cell activity, as well as autoantibody production in patients with exacerbated IPF [74]. Here, ANXA1 is linked to idiopathic pulmonary fibrosis.